106 related articles for article (PubMed ID: 12498909)
1. Screening of novel pentacyclo-undecylamines for neuroprotective activity.
Geldenhuys WJ; Terre'Blanche G; Van der Schyf CJ; Malan SF
Eur J Pharmacol; 2003 Jan; 458(1-2):73-9. PubMed ID: 12498909
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
Araki T; Kumagai T; Matsubara M; Ido T; Imai Y; Itoyama Y
Metab Brain Dis; 2000 Sep; 15(3):193-201. PubMed ID: 11206588
[TBL] [Abstract][Full Text] [Related]
3. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice.
Tabatabaei A; Perry TL; Hansen S; Krieger C
Neurosci Lett; 1992 Jul; 141(2):192-4. PubMed ID: 1436633
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of riluzole in MPTP-treated mice.
Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y
Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
7. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
Oeckl P; Scheffold A; Lechel A; Rudolph KL; Ferger B
Neuroreport; 2014 Mar; 25(5):335-9. PubMed ID: 24525820
[TBL] [Abstract][Full Text] [Related]
8. Increased striatal dopamine turnover following acute administration of rotenone to mice.
Thiffault C; Langston JW; Di Monte DA
Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
[TBL] [Abstract][Full Text] [Related]
9. Effect of D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2017 Jun; 804():38-45. PubMed ID: 28366809
[TBL] [Abstract][Full Text] [Related]
10. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
[TBL] [Abstract][Full Text] [Related]
11. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
12. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
13. Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Oishi T; Hasegawa E; Murai Y
J Neural Transm Park Dis Dement Sect; 1993; 6(1):45-52. PubMed ID: 8105797
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P
Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241
[TBL] [Abstract][Full Text] [Related]
15. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
Khan HA
Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
[TBL] [Abstract][Full Text] [Related]
16. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Yabe H; Choudhury ME; Kubo M; Nishikawa N; Nagai M; Nomoto M
J Pharmacol Sci; 2009 May; 110(1):64-8. PubMed ID: 19403994
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
18. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice.
Boireau A; Bordier F; Dubédat P; Pény C; Impérato A
Neurosci Lett; 1997 Oct; 234(2-3):123-6. PubMed ID: 9364513
[TBL] [Abstract][Full Text] [Related]
20. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]